SN SN
Company Profile ↓Company Overview
SN (SN) is a publicly traded company listed on with a market capitalization of $25.71B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 26.2%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 25.7%.
Net profit has compounded at 44.5% per year over the last five years.
Revenue has grown at a 19.9% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.34.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $6.40B (+15.7% YoY); net profit $701.37M.
- Trailing 12 Months Year-on-year growth — revenue +15.8%, earnings +59.9%.
- 5-Year Trend Long-term compounding — revenue CAGR 19.9%, profit CAGR 44.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 19.85% |
| 1 Year: | 15.75% |
Compounded Profit Growth
| 5 Years: | 44.52% |
| 1 Year: | 59.87% |
Stock Price Performance
| 1 Year: | +62.13% |
| 6 Months: | +52.48% |
| 3 Months: | +55.11% |
| 1 Month: | +20.65% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)79.23 · Overbought
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 26.2%.
- Healthy ROCE of 25.7%.
- Compounding revenue at 19.9% over 5 years.
- Profit CAGR of 44.5% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- RSI at 79 suggests overbought conditions.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 1.22B | 1.44B | 1.63B | 2.10B | 1.41B |
| Cost of Revenue | 619.41M | 736.71M | 812.77M | 1.09B | 717.84M |
| Gross Profit | 603.23M | 708.17M | 817.47M | 1.01B | 694.97M |
| Operating Expenses | 458.28M | 539.52M | 554.58M | 663.83M | 530.44M |
| Operating Income | 144.95M | 168.65M | 262.89M | 343.80M | 164.53M |
| EBITDA | 190.11M | 229.72M | 290.45M | 378.23M | 192.64M |
| Interest Expense | 12.63M | 13.77M | 12.78M | 9.42M | 6.61M |
| Pretax Income | 145.53M | 180.88M | 243.99M | 329.87M | 147.58M |
| Tax Provision | 27.70M | 41.29M | 55.26M | 74.66M | 26.12M |
| Net Income | 117.83M | 139.60M | 188.73M | 255.21M | 121.46M |
| Diluted EPS | 0.83 | 0.98 | 1.33 | 1.80 | 0.85 |
| R&D Expense | 87.60M | - | - | - | 98.88M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 3.72B | 4.25B | 5.53B | 6.40B |
| Cost of Revenue | 2.31B | 2.35B | 2.87B | 3.26B |
| Gross Profit | 1.41B | 1.91B | 2.66B | 3.14B |
| Operating Expenses | 1.09B | 1.53B | 2.02B | 2.22B |
| Operating Income | 321.37M | 373.56M | 644.16M | 920.28M |
| EBITDA | 415.71M | 441.96M | 759.29M | 1.09B |
| Interest Expense | 27.02M | 44.91M | 63.72M | 48.60M |
| Pretax Income | 301.98M | 293.23M | 572.47M | 900.28M |
| Tax Provision | 69.63M | 126.15M | 133.76M | 198.90M |
| Net Income | 232.35M | 167.08M | 438.70M | 701.37M |
| Diluted EPS | 1.67 | 1.20 | 3.11 | 4.94 |
| R&D Expense | - | 249.39M | 341.29M | 368.07M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 3.29B | 3.49B | 4.39B | 5.35B |
| Current Assets | - | 1.72B | 1.90B | 2.64B | 3.61B |
| Cash & Equivalents | - | 192.89M | 154.06M | 363.67M | 777.29M |
| Inventory | - | 548.59M | 699.74M | 899.99M | 1.00B |
| Receivables | - | 766.50M | 985.17M | 1.27B | 1.67B |
| Total Liabilities | - | 1.47B | 2.01B | 2.46B | 2.67B |
| Current Liabilities | - | 968.70M | 1.13B | 1.53B | 1.77B |
| Long Term Debt | - | 349.17M | 775.48M | 736.14M | 696.79M |
| Total Debt | - | 510.96M | 871.07M | 938.99M | 901.52M |
| Total Equity | - | 1.83B | 1.48B | 1.94B | 2.68B |
| Shares Outstanding | - | 138.98M | 139.08M | 140.35M | 141.16M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 204.96M | 280.60M | 446.62M | 634.13M |
| Investing Cash Flow | - | -52.38M | -118.08M | -151.18M | -159.78M |
| Financing Cash Flow | - | -160.17M | -234.87M | -81.22M | -77.08M |
| Capital Expenditure | - | -94.43M | -131.80M | -151.18M | -159.78M |
| Free Cash Flow | - | 110.53M | 148.80M | 295.44M | 474.35M |
| Net Change in Cash | - | -7.59M | -72.34M | 214.22M | 397.27M |
| Dividends Paid | - | - | 150.18M | 0 | 0 |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | 37.9% | 44.9% | 48.1% | 49.0% |
| Operating Margin % | 8.6% | 8.8% | 11.7% | 14.4% |
| Net Margin % | 6.3% | 3.9% | 7.9% | 11.0% |
| ROE % | 12.7% | 11.3% | 22.7% | 26.2% |
| ROCE % | 13.8% | 15.8% | 22.5% | 25.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SN
Why SharkNinja (SN) Stock Is Up Today - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMif0FVX3lxTFBZQjc2MjZIeHA3MnNkNllGQ2lmNk5CaGU2NUZzN3p6bUNFaGl4TVk4T1BZTmp6V3hIV09CVTNsZDlEZGw2eWM2OUxsMEZQVHlMbnNBVXFHUERNMU9kdlRHMEt3eDdOaDNVdWVDeW1MbFo5MVJqMkFUTnVFSnI1OHM?oc=5" target="_bla…
SharkNinja Beats June-Quarter Views Amid Hot Device Sales - Investor's Business Daily
<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxOYTFwYkFTSTNOOEV1WlYwZlZFSkRpb0RGeE9RTEI1SEpYenMyTjBnYV9TUDVRSUJqNTlEUWxfZENwMmdaczJrdGwzVzU0OURkV2ViT2FUTmRheGl6eWdNbUxrb3Izd3FVQ19mUUtKekNsNW9qTFZiaUFvOE41emoxSTZxS1Nrdw?oc=5" t…
SharkNinja Expects $247M Tariff Refund Benefit After Claims Accepted - Stock Titan
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNaFVRcVBGcFhQbWtFMGJWZ3lrem96SDRzUldXUVE2aWhNSUpqVUdQU2p2YV8tMzQyVVI5WWJPSnJUVGkxXzk3QU9KRjVTUl9WMFctVEVKcjIwZUUzdnVHMm9rUHI4QjcwQUhXLUpFS1hmaVN0S2FJQ04xWmpaZ2twc3V4aXpQaTE1YjJUY2…
SharkNinja (SN) Is Up 5.2% After Innovation-Led Q2 2026 Update Reshapes Its Global Narrative - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxNdXlwOFhRQ2pDX2p0VlVoaHFGcE81NWxwdFRaeDVvZERRXzg4dEFmbEpsRE5qRjVrd0IwZlpPZmpHdFlWSXlTUWpVbXVHNEtCWVlvenozYUtRbURHeU9jQ2pkbGIyajdRTXBvSVJQbHNHMXdnNnJHNWFXVDllQXktUlFZSlRYS0E4ZDhheU…
How (SN) Movements Inform Risk Allocation Models - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxOSVdaUk02cGRRTXNpTlJRbjdERk56VWxIMUVFMzNXd0k4U244d2ZUbTVrc1JObks3RW1tbWxaY21pejd6YkRzUjlDMzY3VkxSOXJ3eXZlb0VGbVV1RmlmQ2NoVzNCMjVYemwtbnNSeGptNmRzVUVCNlRFSGFFcXBtWm1zaDVZWDlYOWZKRF…
SharkNinja (SN) Stock Valuation Check After Strong Recent Share Price Performance - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQQ1I3Ylozd2J1UFlfZGlha0pfUl9OV0hNeEs5S2tBNmpaaS1NY1NLZW5udXBGdC1jakVob20wbkRQSjJacENOODB2VGlNTHM5TlRrVlFoT0V5RHdxRnZOTTBDQnhwWW9YVGdRMGRJXzJJYWRONERrLXRBWjN5SDdaSERHTm9kR25jR3ZmZD…
SN — Frequently Asked Questions
What is the current share price of SN?
As of 2026-08-05 17:25 PDT, SN trades at $182.11 on NASDAQ/NYSE. Its 52-week range is $84.57 to $182.11.
What is the market capitalisation of SN?
SN has a market capitalisation of $25.71B on NASDAQ/NYSE.
What is the P/E ratio of SN?
SN trades at a trailing price-to-earnings (P/E) ratio of 36.86. Its price-to-book (P/B) ratio is 9.61.
What is the return on equity (ROE) of SN?
SN has a return on equity (ROE) of 26.21%. Its return on capital employed (ROCE) is 25.74%.
Is SN a good stock to buy?
This page provides a data-driven analysis of SN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.